X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-04-09 | IMVT | Barnett Eva Renee | CFO | S - Sale | $31.18 | -3,689 | 371,709 | -1% | -$115,023 | ||||||
2024-04-09 | IMVT | Butchko Julia G. | Chief Development Officer | S - Sale | $31.18 | -1,053 | 461,742 | 0% | -$32,833 | ||||||
2024-04-09 | IMVT | Salzmann Peter | CEO | S - Sale | $31.18 | -4,807 | 1,086,958 | 0% | -$149,882 | ||||||
2024-02-22 | IMVT | Barnett Eva Renee | CFO | S - Sale | $36.15 | -2,930 | 320,420 | -1% | -$105,920 | ||||||
2024-02-22 | IMVT | Levine Mark S. | GC | S - Sale | $36.15 | -2,134 | 301,968 | -1% | -$77,144 | ||||||
2024-02-22 | IMVT | Macias William L. | Chief Medical Officer | S - Sale | $36.15 | -2,221 | 330,952 | -1% | -$80,289 | ||||||
2024-02-22 | IMVT | Butchko Julia G. | Chief Development Officer | S - Sale | $36.15 | -2,146 | 407,817 | -1% | -$77,578 | ||||||
2024-02-22 | IMVT | Salzmann Peter | CEO | S - Sale | $36.15 | -13,454 | 931,231 | -1% | -$486,362 | ||||||
2024-01-26 | IMVT | Levine Mark S. | GC | S - Sale | $37.92 | -3,027 | 304,102 | -1% | -$114,778 | ||||||
2024-01-26 | IMVT | Geffner Michael | Chief Medical Officer | S - Sale | $37.92 | -10,101 | 89,899 | -10% | -$383,012 | ||||||
2024-01-18 | IMVT | Macias William L. | Chief Medical Officer | S - Sale | $41.03 | -424 | 333,173 | 0% | -$17,397 | ||||||
2024-01-11 | IMVT | Barnett Eva Renee | CFO | S - Sale | $41.83 | -3,515 | 323,350 | -1% | -$147,023 | ||||||
2024-01-05 | IMVT | Butchko Julia G. | Chief Development Officer | S - Sale | $38.59 | -1,297 | 409,963 | 0% | -$50,051 | ||||||
2024-01-05 | IMVT | Salzmann Peter | CEO | S - Sale | $38.59 | -3,824 | 944,685 | 0% | -$147,568 | ||||||
2023-12-01 | IMVT | Fromkin Andrew J. | Dir | S - Sale | $39.73 | -12,350 | 88,658 | -12% | -$490,697 | ||||||
2023-12-01 | IMVT | Pande Atul | Dir | S - Sale | $39.73 | -12,350 | 103,158 | -11% | -$490,668 | ||||||
2023-12-01 | IMVT | Migausky George V | Dir | S - Sale | $39.73 | -12,700 | 109,808 | -10% | -$504,567 | ||||||
2023-11-22 | IMVT | Salzmann Peter | CEO | S - Sale | $32.78 | -16,217 | 948,509 | -2% | -$531,581 | ||||||
2023-11-22 | IMVT | Barnett Eva Renee | CFO | S - Sale | $32.78 | -4,055 | 326,865 | -1% | -$132,920 | ||||||
2023-11-22 | IMVT | Butchko Julia G. | Chief Development Officer | S - Sale | $32.78 | -3,265 | 411,260 | -1% | -$107,024 | ||||||
2023-11-22 | IMVT | Macias William L. | Chief Medical Officer | S - Sale | $32.78 | -3,265 | 333,597 | -1% | -$107,024 | ||||||
2023-11-22 | IMVT | Levine Mark S. | GC | S - Sale | $32.78 | -3,252 | 307,129 | -1% | -$106,598 | ||||||
2023-10-25 | IMVT | Levine Mark S. | GC | S - Sale | $34.66 | -4,107 | 310,381 | -1% | -$142,349 | ||||||
2023-10-19 | IMVT | Macias William L. | Chief Medical Officer | S - Sale | $36.80 | -530 | 336,862 | 0% | -$19,504 | ||||||
2023-10-10 | IMVT | Barnett Eva Renee | CFO | S - Sale | $36.92 | -4,557 | 330,920 | -1% | -$168,244 | ||||||
2023-10-05 | IMVT | Butchko Julia G. | Chief Development Officer | S - Sale | $36.25 | -1,735 | 414,525 | 0% | -$62,885 | ||||||
2023-10-05 | IMVT | Salzmann Peter | CEO | S - Sale | $36.25 | -5,239 | 964,726 | -1% | -$189,887 | ||||||
2023-10-02 | IMVT | Roivant Sciences Ltd. | Dir, 10% | P - Purchase | $38.00 | +1,526,316 | 79,805,331 | +2% | +$58,000,008 | ||||||
2023-08-30 | IMVT | Salzmann Peter | CEO | S - Sale | $22.02 | -56,774 | 969,965 | -6% | -$1,250,338 | ||||||
2023-08-24 | IMVT | Levine Mark S. | GC | S - Sale | $20.30 | -12,286 | 314,488 | -4% | -$249,406 | ||||||
2023-08-24 | IMVT | Barnett Eva Renee | CFO | S - Sale | $20.30 | -14,386 | 335,477 | -4% | -$292,036 | ||||||
2023-08-24 | IMVT | Butchko Julia G. | Chief Development Officer | S - Sale | $20.30 | -12,333 | 416,260 | -3% | -$250,360 | ||||||
2023-08-24 | IMVT | Macias William L. | Chief Medical Officer | S - Sale | $20.30 | -12,333 | 337,392 | -4% | -$250,360 | ||||||
2023-08-14 | IMVT | Salzmann Peter | CEO | S - Sale | $21.42 | -103,058 | 1,026,739 | -9% | -$2,207,178 | ||||||
2023-08-07 | IMVT | Salzmann Peter | CEO | S - Sale | $21.73 | -101,339 | 1,129,797 | -8% | -$2,202,096 | ||||||
2023-07-26 | IMVT | Levine Mark S. | GC | S - Sale | $21.63 | -3,917 | 326,774 | -1% | -$84,725 | ||||||
2023-07-19 | IMVT | Macias William L. | Chief Medical Officer | S - Sale | $24.94 | -426 | 349,725 | 0% | -$10,624 | ||||||
2023-07-19 | IMVT | Barnett Eva Renee | CFO | S - Sale | $24.94 | -2,725 | 349,863 | -1% | -$67,962 | ||||||
2023-07-12 | IMVT | Salzmann Peter | CEO | S - Sale | $19.73 | -3,233 | 1,231,136 | 0% | -$63,787 | ||||||
2023-07-12 | IMVT | Butchko Julia G. | Chief Development Officer | S - Sale | $19.73 | -1,470 | 428,593 | 0% | -$29,003 | ||||||
2023-04-25 | IMVT | Macias William L. | Chief Medical Officer | S - Sale | $16.29 | -509 | 350,151 | 0% | -$8,292 | ||||||
2023-04-25 | IMVT | Levine Mark S. | GC | S - Sale | $16.29 | -2,633 | 330,691 | -1% | -$42,892 | ||||||
2023-04-18 | IMVT | Barnett Eva Renee | CFO | S - Sale | $15.27 | -3,423 | 352,588 | -1% | -$52,269 | ||||||
2023-04-18 | IMVT | Butchko Julia G. | Chief Development Officer | S - Sale | $15.27 | -1,544 | 430,063 | 0% | -$23,577 | ||||||
2023-04-18 | IMVT | Salzmann Peter | CEO | S - Sale | $15.27 | -3,395 | 1,234,369 | 0% | -$51,842 | ||||||
2023-02-02 | IMVT | Macias William L. | Chief Medical Officer | S - Sale | $18.24 | -537 | 262,996 | 0% | -$9,795 | ||||||
2023-01-26 | IMVT | Levine Mark S. | GC | S - Sale | $18.51 | -10,156 | 245,660 | -4% | -$187,988 | ||||||
2023-01-11 | IMVT | Salzmann Peter | CEO | S - Sale | $16.80 | -4,021 | 993,932 | 0% | -$67,553 | ||||||
2023-01-11 | IMVT | Butchko Julia G. | Chief Dev., Tech. Officer | S - Sale | $16.79 | -60,490 | 331,419 | -15% | -$1,015,596 | ||||||
2023-01-11 | IMVT | Barnett Eva Renee | CFO | S - Sale | $16.75 | -4,510 | 268,347 | -2% | -$75,525 | ||||||
2023-01-11 | IMVT | Macias William L. | Chief Medical Officer | S - Sale | $16.75 | -44,568 | 263,533 | -14% | -$746,317 | ||||||
2022-10-21 | IMVT | Macias William L. | Chief Medical Officer | S - Sale | $9.67 | -341 | 308,101 | 0% | -$3,297 | ||||||
2022-10-13 | IMVT | Butchko Julia G. | Chief Dev., Tech. Officer | S - Sale | $9.18 | -928 | 391,909 | 0% | -$8,519 | ||||||
2022-10-13 | IMVT | Salzmann Peter | CEO | S - Sale | $9.18 | -2,793 | 997,953 | 0% | -$25,640 | ||||||
2022-10-11 | IMVT | Barnett Eva Renee | CFO | S - Sale | $9.44 | -12,500 | 272,857 | -4% | -$118,000 | ||||||
2022-10-06 | IMVT | Roivant Sciences Ltd. | 10% | P - Purchase | $6.00 | +416,667 | 73,805,331 | +1% | +$2,500,002 | ||||||
2022-09-30 | IMVT | Pande Atul | Dir | P - Purchase | $5.60 | +15,000 | 102,985 | +17% | +$84,000 | ||||||
2022-09-28 | IMVT | Butchko Julia G. | Chief Dev., Tech. Officer | S - Sale | $4.67 | -535 | 392,837 | 0% | -$2,498 | ||||||
2022-09-28 | IMVT | Salzmann Peter | CEO | S - Sale | $4.67 | -1,605 | 1,000,746 | 0% | -$7,495 | ||||||
2022-09-29 | IMVT | Torti Frank | Dir | P - Purchase | $5.81 | +20,000 | 393,358 | +5% | +$116,200 | ||||||
2022-08-30 | IMVT | Salzmann Peter | CEO | S - Sale | $5.83 | -1,644 | 1,002,351 | 0% | -$9,585 | ||||||
2022-08-30 | IMVT | Butchko Julia G. | Chief Dev., Tech. Officer | S - Sale | $5.83 | -548 | 393,372 | 0% | -$3,195 | ||||||
2022-07-27 | IMVT | Butchko Julia G. | Chief Dev., Tech. Officer | S - Sale | $4.27 | -510 | 281,104 | 0% | -$2,178 | ||||||
2022-07-27 | IMVT | Salzmann Peter | CEO | S - Sale | $4.27 | -1,528 | 552,731 | 0% | -$6,525 | ||||||
2022-07-22 | IMVT | Macias William L. | Chief Medical Officer | S - Sale | $4.70 | -322 | 195,626 | 0% | -$1,513 | ||||||
2022-06-29 | IMVT | Salzmann Peter | CEO | S - Sale | $4.02 | -1,376 | 554,259 | 0% | -$5,532 | ||||||
2022-06-29 | IMVT | Butchko Julia G. | Chief Dev., Tech. Officer | S - Sale | $4.02 | -460 | 281,614 | 0% | -$1,849 | ||||||
2022-05-24 | IMVT | Butchko Julia G. | Chief Dev., Tech. Officer | S - Sale | $3.79 | -492 | 282,074 | 0% | -$1,865 | ||||||
2022-05-24 | IMVT | Salzmann Peter | CEO | S - Sale | $3.79 | -1,471 | 555,635 | 0% | -$5,575 | ||||||
2022-04-27 | IMVT | Butchko Julia G. | Chief Dev., Tech. Officer | S - Sale | $4.72 | -541 | 282,566 | 0% | -$2,554 | ||||||
2022-04-27 | IMVT | Salzmann Peter | CEO | S - Sale | $4.72 | -1,622 | 557,106 | 0% | -$7,656 | ||||||
2022-04-19 | IMVT | Macias William L. | Chief Medical Officer | S - Sale | $4.98 | -1,392 | 195,948 | -1% | -$6,932 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |